Development Level

Tbio 40 | 10,625
Tchem 22 | 1,890
Tclin 9 | 602
Tdark 1 | 7,003

Collection

Eligible Kinase Proteins 1 | 134

IMPC Term

embryonic lethality prior to t... 5 | 187
preweaning lethality, complete... 5 | 633
preweaning lethality, incomple... 3 | 260
abnormal retina morphology 2 | 100
embryonic lethality prior to o... 2 | 148
abnormal behavior 1 | 226
abnormal bone mineralization 1 | 55
abnormal coat/hair pigmentatio... 1 | 54
abnormal embryo size 1 | 112
abnormal femur morphology 1 | 14
abnormal forebrain development 1 | 18
abnormal forelimb morphology 1 | 2
abnormal head morphology 1 | 10
abnormal hindbrain development 1 | 24
abnormal lens morphology 1 | 73
abnormal midbrain development 1 | 22
abnormal neural tube closure 1 | 37
abnormal optic disc morphology 1 | 10
abnormal response to tactile s... 1 | 16
abnormal retinal pigmentation 1 | 61
abnormal startle reflex 1 | 14
cataract 1 | 26
corneal opacity 1 | 25
decreased CD4-positive, alpha ... 1 | 19
decreased T cell number 1 | 31
decreased circulating fructosa... 1 | 31
decreased circulating insulin ... 1 | 75
decreased circulating triglyce... 1 | 83
decreased lean body mass 1 | 195
decreased leukocyte cell numbe... 1 | 54
decreased spleen weight 1 | 13
decreased total body fat amoun... 1 | 186
enlarged heart 1 | 111
increased B cell number 1 | 23
increased bone mineral content 1 | 92
increased bone mineral density 1 | 52
increased circulating alkaline... 1 | 119
increased lean body mass 1 | 107
increased respiratory quotient 1 | 12
syndactyly 1 | 4

Disease

ovarian cancer 52 | 8,484
osteosarcoma 45 | 7,933
Cancer 40 | 2,346
glioblastoma 39 | 5,572
atypical teratoid / rhabdoid tumor 37 | 4,369
lung cancer 31 | 4,466
medulloblastoma, large-cell 30 | 6,234
Carcinoma 29 | 2,147
psoriasis 28 | 6,685
pilocytic astrocytoma 27 | 3,086
intraductal papillary-mucinous neoplasm (IPMN) 26 | 3,289
invasive ductal carcinoma 26 | 2,950
Breast cancer 25 | 3,094
non-small cell lung cancer 25 | 2,798
pediatric high grade glioma 23 | 2,712
primitive neuroectodermal tumor 23 | 3,031
oligodendroglioma 21 | 2,849
pancreatic cancer 21 | 2,300
malignant mesothelioma 19 | 3,162
medulloblastoma 19 | 1,524
ependymoma 18 | 2,514
intraductal papillary-mucinous carcinoma (IPMC) 18 | 2,988
ductal carcinoma in situ 17 | 1,745
interstitial cystitis 17 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 17 | 2,956
astrocytoma 16 | 1,493
lung adenocarcinoma 16 | 2,713
group 4 medulloblastoma 15 | 1,875
lung carcinoma 15 | 2,844
breast carcinoma 14 | 1,614
diabetes mellitus 14 | 1,663
posterior fossa group A ependymoma 14 | 1,511
subependymal giant cell astrocytoma 14 | 2,287
Kidney disease 13 | 396
pancreatic ductal adenocarcinoma liver metastasis 13 | 1,795
primary pancreatic ductal adenocarcinoma 13 | 1,271
Pick disease 12 | 1,893
Rheumatoid Arthritis 12 | 1,160
Stomach Neoplasms 12 | 282
adrenocortical carcinoma 12 | 1,427
astrocytic glioma 12 | 2,241
Neoplasm Invasiveness 11 | 127
acute quadriplegic myopathy 11 | 1,157
dermatomyositis 11 | 933
juvenile dermatomyositis 11 | 1,189
pituitary cancer 11 | 1,972
ulcerative colitis 11 | 2,087
Mammary Neoplasms 10 | 410
Multiple myeloma 10 | 1,327
Neoplasm Metastasis 10 | 138
adult high grade glioma 10 | 2,148
esophageal adenocarcinoma 10 | 737
spina bifida 10 | 1,064
Alzheimer's disease 9 | 644
Craniofacial Abnormalities 9 | 147
Intellectual disability 9 | 573
Lung Neoplasms 9 | 171
Obesity 9 | 616
Squamous cell carcinoma 9 | 94
Waldenstrons macroglobulinemia 9 | 765
Colorectal Neoplasms 8 | 217
Prostatic Neoplasms 8 | 471
cystic fibrosis 8 | 1,665
pancreatic carcinoma 8 | 567
tuberculosis 8 | 1,557
Animal Mammary Neoplasms 7 | 136
Colonic Neoplasms 7 | 126
Liver carcinoma 7 | 217
Mammary Neoplasms, Experimental 7 | 150
Vascular disease 7 | 281
colon cancer 7 | 1,475
cutaneous lupus erythematosus 7 | 1,056
ovarian neoplasm 7 | 97
sonic hedgehog group medulloblastoma 7 | 1,482
Adenoma 6 | 165
Bladder Neoplasm 6 | 109
Esophageal Neoplasms 6 | 67
IGA Glomerulonephritis 6 | 454
Kidney cancer 6 | 118
autosomal dominant Emery-Dreifuss muscular dystrophy 6 | 499
group 3 medulloblastoma 6 | 2,254
Adenocarcinoma 5 | 115
Bipolar Disorder 5 | 266
Cleft palate 5 | 125
Duchenne muscular dystrophy 5 | 602
Heart disease 5 | 279
Juvenile arthritis 5 | 124
Neoplastic Cell Transformation 5 | 81
Osteoporosis 5 | 257
Schizophrenia 5 | 501
Skin Neoplasms 5 | 49
Ureteral disease 5 | 23
acute myeloid leukemia 5 | 780
mucosa-associated lymphoid tissue lymphoma 5 | 480
primary Sjogren syndrome 5 | 789
Attention deficit hyperactivity disorder 4 | 156
Crohn's disease 4 | 304
Down syndrome 4 | 548
fibroadenoma 4 | 557
gastric carcinoma 4 | 832

Tissue

Blood and immune system 72 | 17,995
Cardiovascular System 72 | 17,958
Digestive Tract 72 | 18,473
Endocrine System 72 | 18,512
Female tissues 72 | 18,647
Liver and Pancreas 72 | 18,136
Male tissues 72 | 17,969
Nervous System 72 | 18,561
Respiratory system 72 | 17,484
Skin and soft tissues 72 | 18,115
Urinary Tract 72 | 18,444

Target Family

Non-IDG 28 | 11,971
Kinase 20 | 634
Enzyme 13 | 4,146
Transcription Factor 9 | 1,400
Epigenetic 2 | 242

KEGG Pathway

Adherens junction 72 | 72
Metabolic pathways 1,254 | 1,254
Olfactory transduction 412 | 412
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Ribosome 134 | 134
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Autoimmune thyroid disease 130 | 130
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Oocyte meiosis 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Wiskott-Aldrich syndrome protein family member 3 WASF3 Tbio Non-IDG -2.43045 280.1 123
Receptor-type tyrosine-protein phosphatase eta PTPRJ Tbio Enzyme -1.94494 110.6 235
Fibroblast growth factor receptor 1 FGFR1 Tclin Kinase -3.07424 1194.2 1600
Low molecular weight phosphotyrosine protein phosphatase ACP1 Tchem Enzyme -2.42254 282.0 209
Mothers against decapentaplegic homolog 3 SMAD3 Tbio Transcription Factor -3.03840 1043.2 1391
Catenin alpha-1 CTNNA1 Tbio Non-IDG -1.91334 73.6 399
Transforming protein RhoA RHOA Tbio Enzyme -3.48838 3096.5 467
Catenin alpha-2 CTNNA2 Tbio Non-IDG -1.96886 96.0 66
Receptor-type tyrosine-protein phosphatase mu PTPRM Tbio Enzyme -1.82581 68.8 135
Wiskott-Aldrich syndrome protein family member 2 WASF2 Tbio Non-IDG -2.82062 683.7 211